Skip to main content
OpenTrials
Completed

NCT Number: NCT01306110

Screening for Liver Fibrosis by Using Non-invasive Methods in Patients With Diabetes. A Prospective Study

The aim of this study is to evaluate liver fibrosis using FibroScan and biochemical markers in patients with diabetes.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Diabetes Diabetes Mellitus Digestive System Diseases Endocrine System Diseases Fibrosis Glucose Metabolism Disorders Liver Cirrhosis Liver Diseases Metabolic Diseases Nutritional and Metabolic Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Service Hepato-Gastroentérologie Hopital Haut-Leveque

Pessac, 33604, France

About this study

Patients with diabetes are at risk for nonalcoholic fatty liver disease (NAFLD) leading to advanced fibrosis, cirrhosis, and liver cancer. However, liver fibrosis screening in this large population needs non-invasive methods. Recently, FibroScan was shown to be a good method for the diagnosis of advanced fibrosis in NAFLD patients. We examined the efficacy of a screening strategy with a noninvasive fibrosis biomarker (FibroTest) and transient elastography (FibroScan) in patients with diabetes.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male or female subjects
  • More than 18 years of age
  • Patients with Diabetes
  • Written informed consent

Exclusion criteria

  • Patients refusing to participate to the study and to provide written informed consent

Sponsors and collaborators

Lead sponsor

Association HGE CHU Bordeaux Sud

Other

Registry information

Acronym: DIABSCAN

Important dates

Study start
2007
Primary completion
2010
Study completion
2010
First posted
Mar 1, 2011
Registry last updated
Jan 8, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.